Zev Nakamura is a Psychiatry physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 78 publications with 1,550 citations (h-index 17); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
- Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
Sponsor: University of North Carolina, Chapel Hill
- The Families Addressing Cancer Together Intervention for Parents With Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SNRI27.5%Duloxetine Hcl100%Part D<11 patientsCentral Nervous System Stimulant25.5%Dextroamphetamine-Amphetamine100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Memantine and Exercise for Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer
Univ of North Carolina Chapel Hill
FY2026$187,166K23AG086604 - Memantine and Exercise for Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer
Univ of North Carolina Chapel Hill
FY2025$178,613K23AG086604 - Memantine and Exercise for Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer
Univ of North Carolina Chapel Hill
FY2024$181,626K23AG086604
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”